| JPMORGAN ETFS(IRL)ICAV-US RESEARCH ENHANCED INDEX EQUITY ACTIVE UCITS ETF USD (DIST) | RVI USA | 19,10% | 68,60% | 85,39% | · |
| JPMORGAN ETFS(IRL)ICAV-US RESEARCH ENHANCED INDEX EQUITY SRI PARIS ALIGNED ACTIVE UCITS ETF CHF H A | RVI USA | 9,11% | 64,12% | · | · |
| JPMORGAN ETFS(IRL)ICAV-US RESEARCH ENHANCED INDEX EQUITY SRI PARIS ALIGNED ACTIVE UCITS ETF EUR A | RVI USA | 18,47% | 69,87% | · | · |
| JPMORGAN ETFS(IRL)ICAV-US RESEARCH ENHANCED INDEX EQUITY SRI PARIS ALIGNED ACTIVE UCITS ETF EUR H A | RVI USA | 11,97% | 70,26% | · | · |
| JPMORGAN ETFS(IRL)ICAV-US RESEARCH ENHANCED INDEX EQUITY SRI PARIS ALIGNED ACTIVE UCITS ETF USD A | RVI USA | 18,76% | 70,60% | · | · |
| JPMORGAN ETFS(IRL)ICAV-US RESEARCH ENHANCED INDEX EQUITY SRI PARIS ALIGNED ACTIVE UCITS ETF USD D | RVI USA | 18,09% | 67,64% | · | · |
| JPMORGAN ETFS(IRL)ICAV-US VALUE EQUITY ACTIVE UCITS ETF EUR H (ACC) | RVI USA VALOR | 15,89% | · | · | · |
| JPMORGAN ETFS(IRL)ICAV-US VALUE EQUITY ACTIVE UCITS ETF USD (ACC) | RVI USA VALOR | 22,98% | · | · | · |
| JPMORGAN ETFS(IRL)ICAV-US VALUE EQUITY ACTIVE UCITS ETF USD (DIST) | RVI USA VALOR | 21,58% | · | · | · |
| JPM PACIFIC EQUITY C (ACC) EUR | RVI ASIA PACÍFICO | 21,52% | 66,50% | 31,49% | · |
| JPM PACIFIC EQUITY I2 (ACC) EUR | RVI ASIA PACÍFICO | 21,92% | 67,90% | 33,11% | · |
| JPM PACIFIC EQUITY I2 (ACC) USD | RVI ASIA PACÍFICO | 21,98% | 68,87% | 33,30% | · |
| JPM SGD LIQUIDITY LVNAV CORE (DIST) | RFI ASIA PACÍFICO EX-JAPÓN | 5,03% | · | · | · |
| JPM SGD LIQUIDITY LVNAV E (ACC) | RFI ASIA PACÍFICO EX-JAPÓN | 6,28% | 8,19% | · | · |
| JPM SGD LIQUIDITY LVNAV E (DIST) | RFI ASIA PACÍFICO EX-JAPÓN | 5,03% | 0,67% | · | · |
| JPM TAIWAN I (ACC) USD | RVI CHINA | 104,59% | 219,49% | 199,22% | · |
| JPM THEMATICS-GENETIC THERAPIES A (ACC) CHF (HEDGED) | RVI BIOTECNOLOGÍA | 18,32% | 28,62% | -19,28% | · |
| JPM THEMATICS-GENETIC THERAPIES A (ACC) EUR (HEDGED) | RVI BIOTECNOLOGÍA | 21,13% | 32,79% | -23,46% | · |
| JPM THEMATICS-GENETIC THERAPIES A (ACC) USD | RVI BIOTECNOLOGÍA | 27,05% | 31,88% | -15,82% | · |
| JPM THEMATICS-GENETIC THERAPIES A (DIST) CHF (HEDGED) | RVI BIOTECNOLOGÍA | 18,31% | 28,58% | -19,31% | · |
